Showing results (191-200 of 386) with videos related to
Sort By:
Pageof 39
Breast Cancer Research and Treatment|February 5, 2021
Precursor fractions of neurotensin and enkephalin might point to molecular mechanisms of cancer risk modulation during a lifestyle-intervention in germline BRCA1/2 gene mutation carriersSabine Grill, Maryam Yahiaoui-Doktor, Maryam Basrai, et al.Stress and Health : Journal of the International Society for the Investigation of Stress|November 23, 2023
The different areas of chronic stress and food addiction: Results from the LIFE-Adult-StudyFelix S Hussenoeder, Ines Conrad, Margrit Löbner, et al.Trials|July 13, 2014
Sepsis survivors monitoring and coordination in outpatient health care (SMOOTH): study protocol for a randomized controlled trialKonrad Schmidt, Paul Thiel, Friederike Mueller, et al.Breast Cancer Research and Treatment|September 27, 2021
Physical activity and Mediterranean diet as potential modulators of osteoprotegerin and soluble RANKL in gBRCA1/2 mutation carriers: results of the lifestyle intervention pilot study LIBRE-1Leonie Neirich, Maryam Yahiaoui-Doktor, Jacqueline Lammert, et al.International Journal of Environmental Research and Public Health|July 27, 2022
Different Areas of Chronic Stress and Their Associations with DepressionFelix S Hussenoeder, Ines Conrad, Alexander Pabst, et al.Breast Cancer Research : BCR|December 11, 2012
The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort studyKerstin Rhiem, Christoph Engel, Monika Graeser, et al.BMC Cancer|November 12, 2017
Feasibility of structured endurance training and Mediterranean diet in BRCA1 and BRCA2 mutation carriers - an interventional randomized controlled multicenter trial (LIBRE-1)Marion Kiechle, Ricarda Dukatz, Maryam Yahiaoui-Doktor, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2025
Reclassification of ATM Missense Variants of Uncertain Significance by Integrating Results from Systematic Functional Assays into an ACMG Points-Based FrameworkHelmut Hanenberg, Fan Zhang, Nikita Malev, et al.Human Mutation|September 15, 2018
Diagnosis of Li-Fraumeni Syndrome: Differentiating TP53 germline mutations from clonal hematopoiesis: Results of the observational AGO-TR1 trialKonstantin Weber-Lassalle, Philipp Harter, Jan Hauke, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriersMonika K Graeser, Christoph Engel, Kerstin Rhiem, et al.Pageof 39